{"nct_id":"NCT04666038","title":"Study of LOXO-305 (Pirtobrutinib) Versus Investigator's Choice (Idelalisib Plus Rituximab or Bendamustine Plus Rituximab) in Patients With Previously Treated Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-04","start_date":"2021-03-09","start_date_type":"ACTUAL","primary_completion_date":"2023-08-29","primary_completion_date_type":"ACTUAL","completion_date":"2027-05","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["LLY"]}